Literature DB >> 22609549

Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP.

Katrin Straßburger1, Marcel Tiebe, Federico Pinna, Kai Breuhahn, Aurelio A Teleman.   

Abstract

The insulin/IGF signaling (IIS) pathway is a potent inducer of cell proliferation in normal development and in cancer. The mechanism by which this occurs, however, is not completely understood. The Hippo signaling pathway regulates cell proliferation via the transcriptional co-activator Yorkie/YAP, however the signaling inputs regulating Hippo activity are not fully elucidated. Here we present evidence linking these two conserved, oncogenic pathways in Drosophila and in mammalian cells. We find that activation of IIS and of Yorkie signaling correlate positively in hepatocellular carcinoma. We show that IIS activates Yorkie in vivo, and that Yorkie plays an important role in the ability of IIS to drive cell proliferation. Interestingly, we also find the converse--that Yorkie signaling activates components of the insulin/TOR pathway. In sum, this crosstalk between IIS and Yorkie leads to coordinated regulation of these two oncogenic pathways.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609549     DOI: 10.1016/j.ydbio.2012.05.008

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  75 in total

1.  The Steroid Hormone 20-Hydroxyecdysone Up-regulates Ste-20 Family Serine/Threonine Kinase Hippo to Induce Programmed Cell Death.

Authors:  Du-Juan Dong; Yu-Pu Jing; Wen Liu; Jin-Xing Wang; Xiao-Fan Zhao
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

2.  YAP suppresses gluconeogenic gene expression through PGC1α.

Authors:  Yue Hu; Dong-Ju Shin; Hui Pan; Zhiqiang Lin; Jonathan M Dreyfuss; Fernando D Camargo; Ji Miao; Sudha B Biddinger
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

3.  RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.

Authors:  Hao Yin; Roman L Bogorad; Carmen Barnes; Stephen Walsh; Iris Zhuang; Hidenori Nonaka; Vera Ruda; Satya Kuchimanchi; Lubomir Nechev; Akin Akinc; Wen Xue; Marino Zerial; Robert Langer; Daniel G Anderson; Victor Koteliansky
Journal:  J Hepatol       Date:  2015-11-30       Impact factor: 25.083

4.  Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer.

Authors:  Sun-Hye Jeong; Han-Byul Kim; Min-Chul Kim; Ji-Min Lee; Jae Ho Lee; Jeong-Hwan Kim; Jin-Woo Kim; Woong-Yang Park; Seon-Young Kim; Jae Bum Kim; Haeryoung Kim; Jin-Man Kim; Hueng-Sik Choi; Dae-Sik Lim
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

5.  Cancer metabolism: A waste of insulin interference.

Authors:  Erwin F Wagner; Michele Petruzzelli
Journal:  Nature       Date:  2015-05-28       Impact factor: 49.962

Review 6.  Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies.

Authors:  Min Hwan Kim; Joon Kim
Journal:  Cell Mol Life Sci       Date:  2016-11-08       Impact factor: 9.261

Review 7.  Control of organ growth by patterning and hippo signaling in Drosophila.

Authors:  Kenneth D Irvine; Kieran F Harvey
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-06-01       Impact factor: 10.005

8.  Hippo-YAP and mTOR pathways collaborate to regulate organ size.

Authors:  Alfred Csibi; John Blenis
Journal:  Nat Cell Biol       Date:  2012-12       Impact factor: 28.824

Review 9.  The Hippo pathway: regulators and regulations.

Authors:  Fa-Xing Yu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2013-02-15       Impact factor: 11.361

10.  Excessive Cellular Proliferation Negatively Impacts Reprogramming Efficiency of Human Fibroblasts.

Authors:  Manoj K Gupta; Adrian Kee Keong Teo; Tata Nageswara Rao; Shweta Bhatt; Andre Kleinridders; Jun Shirakawa; Tomozumi Takatani; Jiang Hu; Dario F De Jesus; Rebecca Windmueller; Amy J Wagers; Rohit N Kulkarni
Journal:  Stem Cells Transl Med       Date:  2015-08-07       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.